The inclusion of patient-reported outcome (PRO) measures in chimeric antigen receptor
(CAR) T-cell therapy research is critical for understanding the impact of this novel approach …

Chimeric antigen receptor (CAR) T-cell therapy has transformed the care of patients with
relapsed/refractory B-cell-derived hematologic malignancies. To date, six CAR T-cell …

Caregivers of patients undergoing chimeric antigen receptor T cell therapy (CAR-T) play a
critical role during treatment, yet their experience remains largely unaddressed. We aimed to …

A growing body of literature has emphasized the importance of biobehavioral processes–
defined as the interaction of behavior, psychology, socioenvironmental factors, and …

Objectives Chimeric antigen receptor (CAR)-T cell therapy is a new treatment for patients
with myeloma and other B cell malignancies where advanced practice nurses (APN) can …

Chimeric antigen receptor T-cells and other immunotherapies have markedly changed the
paradigm of treatment for patients with relapsed or refractory hematologic malignancies …

Purpose Patients with advanced melanoma refractory to first-line treatment have a need for
effective second-line treatment options. A recent phase 3 trial showed promising results for …

Adoptive cell therapies (ACT) have demonstrated promise in the treatment of patients with
cancer, leading to long-lasting responses and, in some cases, even cure. Technological …

Abstract Background and Objectives Scholarship on the health of family caregivers to older
adults continues to expand. Although existing research suggests that many family caregivers …

Amaç: Bu çalışma hematoloji hastalarına bakım veren bireylerin yaşam kalitesi ve
depresyon durumlarının değerlendirilmesi amacıyla analitik ve tanımlayıcı olarak yapıldı …